| 2D Structure | |
| CID | 65064 |
| Target | |
| IUPAC Name | [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate |
| InChI | InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1 |
| InChI Key | WMBWREPUVVBILR-WIYYLYMNSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C22H18O11 |
| Molecular Weight | 458.4 |
| synonyms | ['(-)-Epigallocatechin gallate', 'EGCG', '989-51-5', 'Epigallocatechin gallate', 'Tea catechin', 'Epigallocatechin-3-gallate', '(-)-Epigallocatechin-3-o-gallate', 'Teavigo', '(-)-Epigallocatechol gallate', 'L-Epigallocatechin gallate', 'PF-EGCg 90', 'NVP-XAA 723', 'BQM438CTEL', 'epigallocatechin-3-O-gallate', 'CHEBI:4806', 'Epigallocatechingallate', 'DTXSID1029889', 'Epigallocatechin-gallate', 'DTXCID80567', '3-O-Galloyl-(-)-epigallocatechin', 'EPIGALLOCATECHIN 3-O-GALLATE', '(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate', 'EGCG cpd', 'epigallo-catechin gallate', 'GlyTouCan:G31622WS', '(-)-Epigallocatechin-3-gallate', 'G31622WS', '((2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate', '((2S,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl) 3,4,5-trihydroxybenzoate', '(2R-cis)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-Trihydroxybenzoate', 'Epigallocatechin 3-gallate', 'Epigallocatechin-3-monogallate', '(-)-epigallocatechin 3-gallate', 'Catechin deriv.', '(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate', '(-)-epigallocatechin 3-O-gallate', 'MFCD00075940', '(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate', '[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate', '[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate', 'CHEMBL297453', 'C22H18O11', 'Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester', '(-)-Epigallocatechin Gallate (Standard)', 'Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester', "(-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate", '(-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate', 'CAS-989-51-5', 'SMR000449288', 'CCRIS 3729', 'SR-01000759328', 'UNII-BQM438CTEL', 'Epigallocate', 'Sunphenon', 'EPIGALOCATECHIN GALLATE', '(-)-EGCG', 'Epigallocic acid', '2kdh', '3oob', '4awm', 'KDH', 'Epigallocatechol, 3-gallate, (-)-', 'Epigallocatcchin Gallate', 'Spectrum_000316', 'SpecPlus_000277', 'Spectrum2_000168', 'Spectrum3_000244', 'Spectrum4_001541', 'Spectrum5_000102', 'Galloyl-L-epigallocatechol', 'EGCG [WHO-DD]', 'EGCG [MI]', '(-)-Epigallocatechin gallat', '(-)-Epigallocatehin gallate', 'SCHEMBL35258', 'BSPBio_001628', 'epigallocatechin-gallate-(-)', 'KBioGR_002002', 'KBioSS_000796', 'SPECTRUM210239', 'cid_65064', 'MLS000758300', 'MLS001424000', 'DivK1c_006373', 'SPBio_000035', 'Epigallocatechin monogallate, B', 'GTPL7002', 'MEGxp0_001166', 'orb1304766', 'SCHEMBL30014282', 'ACon1_001054', 'KBio1_001317', 'KBio2_000796', 'KBio2_003364', 'KBio2_005932', 'KBio3_001128', 'GLXC-04918', 'HMS2051K21', 'HMS3649E08', 'MSK40118', 'Tox21_201468', 'Tox21_303457', 'BDBM50070942', 'CCG-38378', 'FR-109', 'HY-13653R', 'LMPK12030005', 's2250', 'AKOS015918182', 'CS-1258', 'DB12116', 'DS-9030', 'FE09970', 'NC00078', 'SDCCGMLS-0066550.P001', '(-)-Epigallocatechin gallate, >=95%', '(-)-Epigallocatechin-3-gallate; EGCG', 'NCGC00164319-01', 'NCGC00164319-02', 'NCGC00164319-03', 'NCGC00164319-04', 'NCGC00164319-06', 'NCGC00164319-07', 'NCGC00164319-10', 'NCGC00257243-01', 'NCGC00259019-01', '(-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate)', 'AC-34075', 'BP-30205', 'HY-13653', 'ST097428', 'CS-0694875', 'E0694', 'NS00015163', 'SW197458-3', 'C09731', 'M01719', '(-)-Epigallocatechin gallate, >=97.0% (HPLC)', '(-)-Epigallocatechin gallate, analytical standard', 'Gallic acid, 3-ester with epigallocatechol, (-)-', 'Q393339', 'SR-01000946601', '(-)-EPIGALLOCATECHIN-3-O-GALLATE [USP-RS]', 'SR-01000759328-5', 'SR-01000759328-6', 'SR-01000946601-1', 'BRD-K55591206-001-18-1', 'BRD-K55591206-001-19-9', 'BRD-K55591206-001-20-7', 'Epigallocatechin-3-gallate 1000 microg/mL in Acetonitrile', '(-)-Epigallocatechin gallate, >=80% (HPLC), from green tea', 'Epigallocatechin gallate, primary pharmaceutical reference standard', '(-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard', '(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate', '(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate', '[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate', 'Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material', '(-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate', '(-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE)', '(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate', '[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]3,4,5-trihydroxybenzoate', '2041570-28-7', '3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate', 'Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-'] |
From Pubchem